The assets acquired, which do not include the New York City-based system’s hospital-based labs, comprise $222 million of tax-deductible goodwill and $53 million of customer-related intangible assets. The intangible assets are being amortized over 15 years.
“NewYork-Presbyterian and Quest share a belief that exceptional patient care should be accessible to all,” NewYork-Presbyterian President and CEO Steven Corwin, MD, said in a news release. “We determined that working with Quest would be the best path — allowing our patients wider access to advanced, quality laboratory services.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
